Notes
rabbit antithymocyte globulin
interleukin 2 receptor antagonists
incremental cost-effectiveness ratio
Reference
Gharibi Z, et al. Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States. Transplantation : Jul 2016. Available from: URL: http://doi.org/10.1097/TP.0000000000001310
Rights and permissions
About this article
Cite this article
Antibody-based induction preferred choice in DDRT. PharmacoEcon Outcomes News 758, 10 (2016). https://doi.org/10.1007/s40274-016-3239-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3239-2